시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 정맥내 장비 시장 규모, 점유율, 산업 동향 분석 리포트 : 제품 유형별, 최종사용자별, 지역별 전망과 예측(2023-2030년)
Global Intravenous Equipment Market Size, Share & Industry Trends Analysis Report By Product Type (IV catheters, Infusion Pumps, Administration Sets, Needleless Connectors, and Others), By End User, By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1353334
리서치사 : KBV Research
발행일 : 2023년 08월
페이지 정보 : 영문 213 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,005,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,006,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,408,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

정맥내 장비 시장 규모는 2030년까지 219억 달러에 달할 것으로 예측되며, 예측 기간 중 CAGR은 5.6%의 시장 성장률로 상승할 전망입니다.

또한 COVID-19 팬데믹은 세계 헬스케어 산업에 워크플로우의 혼란을 일으켰고, COVID-19 팬데믹은 시장을 포함한 헬스케어 부문에 큰 영향을 미쳤습니다. 전염병의 결과로 정맥내 치료에 대한 수요가 급증했습니다. 중증 COVID-19 환자들은 효과적인 치료를 위해 정맥주사, 의약품, 지지요법이 필요했습니다. 이에 따라 투약 세트, 카테터, 수액 펌프와 같은 정맥주사 용품에 대한 필요성이 높아졌습니다. 오염이나 바늘 찔림 사고의 위험을 줄이기 위해 안전 설계가 적용된 카테터나 안전장비 등 안전성이 강화된 주입기구가 사용되기 시작했습니다. 따라서 COVID-19는 시장 확대에 큰 도움이 되었습니다.

그러나 정비 및 고장 문제가 상당히 존재합니다. 주입 펌프, 카테터 및 튜브와 같은 정맥내 장비는 최적의 성능과 정확한 약물전달을 위해 자주 정비 및 보정을 수행해야 합니다. 그러나 장비의 고장은 환자 치료를 방해하고 환자에게 건강상의 문제를 일으킬 수 있습니다. 주입 펌프의 고장, 카테터 및 튜브 라인의 막힘 및 누출은 부작용을 유발할 수 있으며 정맥내 치료의 효과를 감소시킬 수 있습니다. 적극적인 유지보수 절차, 제조업체의 지침 준수, 지속적인 품질 개선 프로그램은 시장 성장과 지속가능성을 촉진하는 유지보수 및 장비 고장 문제를 줄이기 위해 매우 중요합니다.

제품 유형 전망

제품 유형별로는 수액 카테터, 수액 펌프, 투약 세트, 니들리스 커넥터, 기타로 나뉩니다. 주입 펌프 분야는 시장에서 큰 매출 점유율을 차지하고 있습니다. 세계에서 많은 특수 주입 펌프가 수용되고 있으므로 주입 펌프 분야가 증가하고 있습니다. 정맥 치료시 제공되는 다양한 특수 수액 펌프 유형에는 이식형 수액 펌프, 경장 펌프, 인슐린 펌프, 환자 제어 진통제(PCA) 펌프 등이 있습니다.

최종사용자별 전망

최종사용자별로 시장은 병원 및 진료소, 재택치료, 기타로 나뉩니다. 병원 및 클리닉 부문은 2022년 시장에서 가장 큰 매출 점유율을 차지했습니다. 이 부문은 중환자실, 응급실, 수술실, 일반 병동과 같이 수액 치료가 널리 사용되는 전문 병원 부서 및 병동에 대한 접근성 및 가용성 등 여러 가지 상황으로 인해 성장하고 있습니다.

지역별 전망

지역별로 보면 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 나뉩니다. 북미 부문은 2022년 시장에서 가장 큰 매출 점유율을 기록했습니다. 북미 부문의 성장은 환자 안전에 대한 강한 헌신, 첨단 기술, 발달된 의료 인프라, 높은 질병 유병률, 강력한 상환 규제, 주요 시장 진출기업 등의 요인에 기인합니다. 이 지역 시장의 정맥주사기 수요는 북미의 병원, 외래수술센터(ASC), 클리닉과 같은 정교한 의료 시설에 의해 주도되고 있습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장의 개요

제3장 시장 개요

제4장 정맥내 장비 시장에서 도입되는 전략

제5장 세계의 정맥내 장비 시장 : 제품 유형별

제6장 세계의 정맥내 장비 시장 : 최종사용자별

제7장 세계의 정맥내 장비 시장 : 지역별

제8장 기업 개요

제9장 정맥내 장비 시장의 획득 필수사항

KSA
영문 목차

영문목차

The Global Intravenous Equipment Market size is expected to reach $21.9 billion by 2030, rising at a market growth of 5.6% CAGR during the forecast period.

Patients who require long-term IV therapies, such as chemotherapy, antibiotics, or parenteral nourishment, may benefit from the comfort and convenience of receiving them at home. Therefore, the Homecare Settings segment registered $2,283.5 million revenue in the market in 2022. Home healthcare gives patients the option to get medical care in a relaxing environment at their homes for treatments like intravenous therapy in an effort to decrease hospital visits and healthcare expenses. Some of the factors impacting the market are innovations in IV solutions technology, increase in the number of surgical operations, and Issues in equipment and its maintenance.

An essential component of contemporary medical practice, IV solutions are used to deliver medications, fluids, and nutrients directly into the bloodstream. The IV solutions demand is being driven by the most recent technological developments in intravenous equipment, which have increased their effectiveness, safety, and efficiency. Intelligent intravenous pumps are one of the most recent technological developments in the IV solution sector. Intelligent IV pumps intelligently change infusion rates based on patient age, weight, and medical condition in order to increase patient safety and lower the possibility of medication errors. Nanotechnology infusion solutions make drug and nutrient delivery to the body more effective and efficient. Additionally, an increase in surgical procedures worldwide is one of the main factors driving the demand for intravenous equipment. Surgical operations encompass a variety of medical interventions that call for medical interventions for various objectives, both in the hospital and outside of it. Infusion pumps, intravenous catheters, and other devices are crucial during surgery for fluid resuscitation, administering anesthetic, and providing postoperative care. Thus, the market will grow due to technological developments in IV solutions and increasing reliance of healthcare providers on these instruments for safe and effective patient care.

Furthermore, The COVID-19 pandemic caused workflow disruptions in the healthcare industry globally. The COVID-19 pandemic had a major effect on the healthcare sector, which included the market. Intravenous treatment saw a spike in demand as a result of the pandemic. Critically ill COVID-19 patients needed intravenous fluids, medicines, and supportive therapies for effective therapy. This raised the need for intravenous supplies such as administration sets, catheters, and infusion pumps. To reduce the danger of contamination and needlestick accidents, intravenous equipment with improved safety features was being used, like safety-engineered catheters and security devices. Therefore, COVID-19 had a largely positive impact on the expansion of the market.

However, substantial maintenance and malfunction issues exist. Intravenous equipment, including infusion pumps, catheters, and tubes, should be frequently maintained and calibrated for optimal performance and accurate medicine delivery. However, device malfunctions could disrupt patient care and pose health concerns to the patients. Failures of the infusion pump, obstructions, or leaks in the catheter and tube lines that may cause adverse effects may reduce the efficacy of intravenous therapy. Proactive maintenance procedures, adherence to manufacturer's instructions, and continual quality improvement programs are crucial to reducing maintenance and equipment failure issues promoting growth and sustainability for the market.

Product Type Outlook

By product type, the market is segmented into IV catheters, infusion pumps, administration sets, needleless connectors, and others. The infusion pumps segment garnered a significant revenue share in the market. There is a rise in the infusion pumps segment due to the increasing acceptance of a number of specialty infusion pumps around the globe. The various specialist infusion pump types that are offered during intravenous therapy include implantable infusion pumps, enteral pumps, insulin pumps, and patient-controlled analgesia (PCA) pumps.

End User Outlook

On the basis of end user, the market is divided into hospitals & clinics, homecare settings, and others. The hospitals and clinics segment held the largest revenue share in the market in 2022. This segment is growing due to a number of circumstances, including the accessibility and availability of specialized hospital departments and units, like ICUs, emergency rooms, surgical suites, and general wards, where IV treatment is widely used.

Regional Outlook

Based on region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the maximum revenue share in the market in 2022. The growth of the North America segment is owing to factors including a strong dedication to patient safety, advanced technology, a well-developed healthcare infrastructure, high illness prevalence, strong reimbursement regulations, and key market participants. The demand for intravenous equipment in the regional market is driven by the sophisticated medical facilities in North America, including hospitals, ambulatory surgical centers, and clinics.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include AngioDynamics, Inc., B. Braun Melsungen AG, ICU Medical, Inc., 3M Company, Teleflex, Inc., Terumo Corporation, Baxter International, Inc., Becton, Dickinson and Company, Vygon and Poly Medicure Limited

Strategies Deployed in Intravenous Equipment Market

Sep-2022: Teleflex Incorporated took over Standard Bariatrics, Inc., a provider of superior Bariatric/Metabolic Surgery clinical and economic outcome solutions for Patients and Healthcare Providers. With this acquisition, Teleflex Incorporated would be able to provide innovative powered stapling technology to their customers, for bariatric surgery.

Sep-2022: B. Braun Melsungen AG completed the acquisition of the Catheter Securement Devices portfolio of Starboard Medical, a medical devices manufacturing company. Through this acquisition, B. Braun would be able to meet the needs and requirements of their customers, as an innovative Clik-FIX portfolio is added to the expertise and commercial capabilities of B. Braun.

Jan-2022: ICU Medical acquired Smiths Medical from Smiths Group PLC. Smith Medical business comprises vascular access, syringe and ambulatory infusion devices, and vital care products. The combined operations, when coupled with ICU Medical's current businesses, created a market-leading infusion therapy company with pro forma combined revenues of about $2.5 billion. The acquisition of Smiths Medical complemented ICU Medical's current operations effectively and provided a sizable US-based international rival that strengthened the medical supply chain's stability and expanded as clinical care models changed.

Dec-2021: Becton, Dickinson, and Company completed the acquisition of Venclose, Inc., a medical technology company that develops solutions for the treatment of chronic venous insufficiency. Through this acquisition, Becton, Dickinson, and Company would be able to deliver a strong portfolio of solutions to the physicians who are treating venous conditions.

Dec-2021: Baxter International, Inc. took over Hillrom, a medical technology company that offers patient support systems, surgical solutions, and front-line care products. Through this acquisition, both companies will be able to accelerate the development process of their products and offerings. Moreover, this acquisition would also help to expand the geographic footprint of Baxter and create new opportunities in the digital health market.

Nov-2019: Terumo Corporation signed an agreement to acquire Aortica Corporation, a U.S.-based company that provides personalized vascular therapy solutions. With this acquisition, Aortica's advanced products and software solutions would be added to Terumo's product portfolio. Moreover, this acquisition would be a great opportunity for both companies to accelerate the development of new and innovative products.

Scope of the Study

Market Segments covered in the Report:

By Product Type

By End User

By Geography

Companies Profiled

Unique Offerings from KBV Research

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Strategies Deployed in Intravenous Equipment Market

Chapter 5. Global Intravenous Equipment Market by Product Type

Chapter 6. Global Intravenous Equipment Market by End User

Chapter 7. Global Intravenous Equipment Market by Region

Chapter 8. Company Profiles

Chapter 9. Winning Imperative for Intravenous Equipment Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기